A+ A-

 

Drug use in prison : practices, consequences and responses
Summary

 

ThemaPrisonSyntheseEN.jpg

Summary, OFDT, 9 p.
December 2020

What is the extent and nature of illicit drug use in prisons in France? What are the consequences and what responses are being provided? Published in December 2019, an issue of the OFDT's Théma collection gave an overview of existing work on these issues based on a twofold approach: a literature review allowing a retrospective over 20 years and a valorisation of the Monitoring Centre's latest productions on the subject.

The state of play drawn up by this publication shows that, despite the growing attention paid to these issues in France, data on drug use in prisons remains too disparate. It should soon be expanded by the prospects set out in the roadmap 2019-2022 concerning inmates and, in particular, the results of new epidemiological surveys.

Authors : Caroline Protais, Julien Morel d’Arleux, Marie Jauffret-Roustide

Download the PDF file (1,06 Mo)

 

Read the complete report in French

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Drugs in Europe


2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.